Patents by Inventor Mark Hochstrasser

Mark Hochstrasser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11832601
    Abstract: The disclosure relates to genetically modified bacteria, genetically modified arthropods, and methods for controlling and/or reducing arthropod populations.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: December 5, 2023
    Assignees: VANDERBILT UNIVERSITY, YALE UNIVERSITY
    Inventors: Jason Metcalf, Seth R. Bordenstein, Daniel Lepage, Sarah Bordenstein, Mark Hochstrasser, John F. Beckmann, Judith Ronau
  • Publication number: 20210102950
    Abstract: Described herein are compositions and methods for detecting the presence of ubiquitination in a sample. The compositions include synthetic peptides containing a high affinity ubiquitin binding domain and an additional peptide sequence that can be coupled to materials such as resins and dyes.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 8, 2021
    Inventors: Mengwen Zhang, Jason Berk, Mark Hochstrasser
  • Patent number: 5565352
    Abstract: The invention relates generally to compositions of and methods for obtaining deubiquitinating enzyme polypeptides. The invention relates as well to polynucleotides encoding deubiquitinating enzyme polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant deubiquitinating enzyme polypeptides. By way of example, the invention discloses the cloning and functional expression if at least three different deubiquitinating enzyme polypeptides. The invention includes as well, methods for using the isolated, recombinant enzyme polypeptides in assays designed to select and improve substances capable of interacting with deubiquitinating enzyme polypeptides for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: November 24, 1993
    Date of Patent: October 15, 1996
    Assignee: Arch Development Corporation
    Inventors: Mark Hochstrasser, Feroz Papa
  • Patent number: 5122463
    Abstract: This invention pertains to a method of metabolically destabilizing a protein or peptide of interest in vivo provided that the protein or peptide contains a second determinant of the N-end rule-based degradation signal and provided that another (targeting) protein or peptide can be identified that specifically interacts with the protein or peptide of interest. The methods of the invention comprise contacting the protein or peptide of interest with the targeting protein or peptide which contains a destabilizing amino-terminal amino acid according to the N-end rule of protein degradation but lacking a second determinant of the N-end rule-based degradation signal. Because nearly all proteins specifically interact with other proteins, this is a broadly applicable method for metabolically destabilizing a protein or peptide of interest in vivo.
    Type: Grant
    Filed: May 17, 1990
    Date of Patent: June 16, 1992
    Assignee: Massachusetts Institute of Technology
    Inventors: Alexander J. Varshavsky, Erica S. Johnson, David K. Gonda, Mark Hochstrasser